HomeMedical SpecialtiesDiseasesManaging mental health while living with diabetes

Managing mental health while living with diabetes

Published on

Scarborough Health Network (SHN) has introduced its new Mental Health Diabetes Clinic, providing diabetes patients, who may also be at risk for chronic kidney disease (CKD), access to necessary mental health supports in addition to regular disease monitoring and management.

“SHN’s diabetes and mental health programs are partnering to expand care for patients living with diabetes. Chronic diseases like diabetes impact many aspects of patients’ lives, including their mental health. With our new clinic, diabetes patients can now be referred to an SHN psychiatrist if they are experiencing depressive, anxiety, post-traumatic, or other psychiatric symptoms that are contributing to difficulties with self-management or engagement in care,” explained Toni Thomas, a registered nurse for SHN’s diabetes program.

The clinic reflects the comprehensive approach of SHN’s diabetes program, which has established itself as a leader in diabetes management, treatment and prevention strategies, ensuring access to timely, high-quality services in the most appropriate setting for patients. It will also support eligible CKD patients, since both kidney disease and diabetes are closely linked.

The new service also builds on support available to patients through SHN’s diabetes and kidney disease (DKD) program, which focuses on slowing the progression of CKD and delaying the transition to dialysis. This is achieved by providing diabetes and nephrology management within one appointment. It is a collaboration with SHN’s regional nephrology program, which cares for more than 6,000 patients annually. The DKD program is paving the way for a Metabolic Clinic in the future – which aims to be a “one-stop shop” for patients including services such as mental health, cardiology, foot and much more.

“Diabetes is actually the top cause of chronic kidney disease,” emphasized Thomas. “Mental health is a largepart of managing a chronic disease and certainly managing diabetes and kidney disease; can be quite onerous on a daily basis. There are many decisions people must make, like medications, diet, and regular daily life, and it can take a toll on mental health,” she explained.

Currently the program is in its pilot stage, only accepting patients referred by SHN doctors, and using the diabetes distress scale (DDS) in identifying individuals for the clinic. The DDS is a 17-item scale that captures four critical dimensions of distress: emotional burden, regimen distress, interpersonal distress and physical distress.

“Diabetes on it’s own can present patients with many challenges, but once you add chronic kidney disease,there are several issues that can manifest. Getting patients the care they need and collaborating between clinicians provides the best care possible for the patient, while improving their mental health,” Thomas added.

An estimated 1.2 million people in Ontario have been diagnosed with Type 1 or Type 2 diabetes, both of which can cause CKD.

Diabetes and kidney disease also have strong prevalence in individuals of Asian, South Asian and Caribbean descent, cultures that comprise much of Scarborough’s population.

Recognizing the need for care in Scarborough, Thomas said patients have more options for treatment, monitoring and mental health supports than ever before.

“Individuals with diabetes and chronic kidney disease can be at higher risk of developing depression than others; for example, untreated or unrecognized mental health issues can make managing chronic diseases more challenging due to the overwhelming amount of responsibilities on a day to day basis,” explained Thomas.

“Diabetes distress can be caused by frustration, worry, and discouragement from dealing with daily disease care, leading some to find it difficult to engage in their daily care. It is important to offer patients effective methods of dealing with their anxiety and depression, and to ensure they are speaking with someone who has a deeper understanding of diabetes and chronic kidney disease challenges—it can be life-saving.”

Learn more about SHN’s diabetesmental health and regional nephrology programs.

 

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill University researchers have developed an artificial intelligence tool that can identify small groups of cells most responsible...

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society (CCS) is calling on provinces and territories to lower the...

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

Doctors report false health information, lack of health data sharing put patient care at risk

Canada's doctors are concerned that false health information and disconnected health systems are putting...

More like this

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill University researchers have developed an artificial intelligence tool that can identify small groups of cells most responsible...

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society (CCS) is calling on provinces and territories to lower the...

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

An individualized and equitable approach: Pregnancy care for people with disabilities

HN Summary • Sunnybrook’s Accessible Care Pregnancy Clinic provides individualized, fully accessible care for people...

First-in-Canada case of sustained HIV remission

HN Summary • A first-in-Canada case shows a patient achieving sustained HIV remission following a...

UHN researchers investigate new therapies as colon cancer rises among young patients

HN Summary • Colorectal cancer is rising among younger adults, prompting UHN researchers to investigate...